Novo Nordisk said patients taking a bigger dose of its blockbuster obesity drug lost more weight than those on a lower dose, ...
Wegovy, the weight-loss brand of semaglutide, has a recommended maintenance dose of 2.4 mg. Novo ran the Phase III STEP UP ...
Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...
The round is one of Europe’s largest-ever biotech VC deals, signalling investor appetite for the booming weight loss market.
Websites selling compounded versions of popular weight-loss drugs from Novo Nordisk and Eli Lilly to U.S. consumers often do ...
Weight loss drugs like Ozempic and Wegovy cost an average of $1,083 per month if you pay ... Many health insurance plans don't cover the weight loss drug Zepbound because it's so new.
There’s still scope for a new generation of drugs to replace weight-loss market leaders like Novo Nordisk A/S’s Wegovy, ...
We meet some of the first NHS patients, as expert says funding everyone eligible would "bankrupt" the service.